TY - JOUR
T1 - Gesundheitsprobleme nach radikaler Prostatektomie
T2 - Welche subjektiven Gesundheitseinschränkungen sind für Langzeitüberlebende relevant?
AU - Klorek, Tobiasz
AU - Schlichte, Anton N.J.H.
AU - Peter, Cornelia
AU - Jahnen, Matthias
AU - Dinkel, Andreas
AU - Schiele, Stefan
AU - Lunger, Lukas
AU - Schulwitz, Helga
AU - Gschwend, Jürgen E.
AU - Herkommer, Kathleen
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024
Y1 - 2024
N2 - Background: Radical prostatectomy (RP) is one of the most common therapeutic strategies for treating localized prostate cancer (PCa). Currently, the significance of postoperative functional limitations for affected patients in the long-term course, especially in comparison to age-related comorbidities, is unclear. Objective: The aim of this study was to quantify the prevalence of subjective health restrictions alongside functional deficits in long-term PCa survivors after RP and their relevance for subjective impairments in everyday life. Materials and methods: Using the German version of the Self-Administered Comorbidity Questionnaire (SCQ-D), 3173 long-term survivors after RP reported their comorbidities in 13 predefined categories and in 3 free-text fields along the dimensions “problem,” “treatment,” and “impairment”. Results: The mean age at survey was 79.5 years (standard deviation, SD ± 6.4), with a mean time since RP of 17.4 years (SD ± 3.7). The three most frequently identified comorbidities/percentage of patients who felt impaired were: hypertension (62.2%/8.5%), back pain (44.1%/54.5%), and osteoarthritis (36.1%/54.1%). The most frequently mentioned additional health problems can be subsumed under the umbrella term “urological problems” (6.1%/72.7%): incontinence (4.8%/74.3%), bladder problems (1.1%/61.8%), and erectile dysfunction (0.5%/47.1%). Conclusion: In summary, non-cancer-related comorbidities in the long-term course after RP are often perceived as “problems” but rarely lead to subjective impairment. In contrast, treatment-related urological problems are rarely reported as “problems”, but they very often lead to subjective impairment in everyday life.
AB - Background: Radical prostatectomy (RP) is one of the most common therapeutic strategies for treating localized prostate cancer (PCa). Currently, the significance of postoperative functional limitations for affected patients in the long-term course, especially in comparison to age-related comorbidities, is unclear. Objective: The aim of this study was to quantify the prevalence of subjective health restrictions alongside functional deficits in long-term PCa survivors after RP and their relevance for subjective impairments in everyday life. Materials and methods: Using the German version of the Self-Administered Comorbidity Questionnaire (SCQ-D), 3173 long-term survivors after RP reported their comorbidities in 13 predefined categories and in 3 free-text fields along the dimensions “problem,” “treatment,” and “impairment”. Results: The mean age at survey was 79.5 years (standard deviation, SD ± 6.4), with a mean time since RP of 17.4 years (SD ± 3.7). The three most frequently identified comorbidities/percentage of patients who felt impaired were: hypertension (62.2%/8.5%), back pain (44.1%/54.5%), and osteoarthritis (36.1%/54.1%). The most frequently mentioned additional health problems can be subsumed under the umbrella term “urological problems” (6.1%/72.7%): incontinence (4.8%/74.3%), bladder problems (1.1%/61.8%), and erectile dysfunction (0.5%/47.1%). Conclusion: In summary, non-cancer-related comorbidities in the long-term course after RP are often perceived as “problems” but rarely lead to subjective impairment. In contrast, treatment-related urological problems are rarely reported as “problems”, but they very often lead to subjective impairment in everyday life.
KW - Impairment
KW - Patient-reported outcomes
KW - Prostate cancer survivors
KW - Subjective health restrictions
KW - “Self-Administered Comorbidity Questionnaire”
UR - http://www.scopus.com/inward/record.url?scp=85204556949&partnerID=8YFLogxK
U2 - 10.1007/s00120-024-02441-0
DO - 10.1007/s00120-024-02441-0
M3 - Artikel
C2 - 39304562
AN - SCOPUS:85204556949
SN - 2731-7064
JO - Urologie
JF - Urologie
ER -